The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s hemoglobin testing market report forecasts the hemoglobin testing market size to grow to $3.36 Billion by 2027, with a CAGR (compound annual growth rate) of more than 7%.

Learn More On The Hemoglobin Testing Market Report 2023 – https://www.thebusinessresearchcompany.com/report/hemoglobin-testing-global-market-report

Hemoglobin Testing Market Size Forecast
The global hemoglobin testing market is expected to grow from $2.39 billion in 2022 to $2.54 billion in 2023 at a compound annual growth rate (CAGR) of 6.49%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global hemoglobin testing market size is expected to reach $3.36 billion in 2027 at a CAGR of 7.26%.

Asia-Pacific held the largest hemoglobin testing market share and was the fastest-growing region in 2022.

Key Hemoglobin Testing Market Driver ­– Rise In The Prevalence Of Chronic Disorders Such As Diabetes
According to the US Census Bureau, a US-based department of the Federal Statistical System, more than 34 million Americans will have diabetes in November 2022, with an additional 88 million at risk. Furthermore, according to the IDF Diabetes Atlas 10th edition released by the International Diabetes Federation, a Belgium-based global diabetes community, diabetes afflicted 536,000 people in 2021, and it is expected to rise to 642,800 by 2030. It will reach 783,700 people worldwide by 2045. As a result, the increasing prevalence of chronic diseases like as anaemia and diabetes will propel the haemoglobin a1c testing equipment market.

Request for A Sample Of The Global Hemoglobin Testing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10059&type=smp

Key Hemoglobin Testing Market Trend – Technological Advancement
Major players in the haemoglobin testing market are focusing on producing unique solutions to increase their market position. For example, Nova Biomedical, a US-based firm that develops blood testing analyzers for medical usage, unveiled the Stat EMS Basic blood testing equipment in April 2020, which can produce lab-calibre results in less than 40 seconds. Stat EMS Basic is an innovative, lightweight soft container that carries all system components—meters, test strips, controls, and lancets—while remaining tiny enough to carry in a medic’s backpack. Because test strips and controls do not need to be refrigerated, testing is both convenient and inexpensive.

Hemoglobin Testing Market Segment
1) By Product: Reagents And Consumables, Equipment
2) By Technology: Chromatography, Immunoassay, Spectrophotometry, Other Technologies
3) By End User: Hospitals, Clinics, Laboratories, Home Care Settings, Blood Banks, Other End Users

Hemoglobin Testing Market Major Players and Strategies
Major players in the hemoglobin testing market are Abbott Laboratories Inc., Bayer Medical Care Inc., Danaher Corp., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, Bio-Rad Laboratories Inc., Daiichi Sankyo Inc., ACON Laboratories Inc., DiaSys Diagnostic Systems GmbH, EKF Diagnostics Holdings PLC, Epinex Diagnostics Inc., Erba Diagnostics Inc., Alere Inc., ARKRAY Inc., Beckman Coulter Diagnostics Ltd., Diazyme Laboratories Inc., Masimo Corp., Radiometer A/S, Sysmex Corporation, BIOMEDOMICS INC., Germaine Laboratories Inc., Hemosure Inc., Humasis Co. Ltd., Immunostics Inc., LifeSign LLC, Medix Biochemica Oy AB, NanoenTek Inc., Nova Biomedical Corp, Quidel Corporation, and TCS Biosciences Ltd.

Hoffmann-La Roche AG, a Swiss pharmaceutical and diagnostic firm, paid an undisclosed sum to buy TIB Molbiol Group in December 2021. F. Hoffmann-La Roche AG strengthened its ability to rapidly develop tests for new pathogens and potential health threats such as infectious diseases as a result of this acquisition. The TIB Molbiol Group is a diagnostics company established in Germany that does blood screening for testing, life science research, and medical diagnostics.

The Hemoglobin Testing Global Market Report 2023 covers regional data on hemoglobin testing market size, hemoglobin testing market trends and drivers, opportunities, strategies, and hemoglobin testing market competitor analysis. The countries covered in the hemoglobin testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Haemoglobin testing is a medical process that determines how much haemoglobin is in the blood. Haemoglobin is a protein found in red blood cells that carries oxygen from the lungs to the body’s tissues and organs.

View More Reports Related To The Hemoglobin Testing Market –
Hemoglobin A1c Testing Devices Global Market Report 2023
Testing, Inspection, And Certification Global Market Report 2023
Testing Software Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: